These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17455416)

  • 21. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of multi drug resistance tuberculosis in the field: Tuberculosis Research Centre experience.
    Thomas A; Ramachandran R; Rehaman F; Jaggarajamma K; Santha T; Selvakumar N; Krishnan N; Mohan NS; Sundaram V; Wares F; Narayanan PR
    Indian J Tuberc; 2007 Jul; 54(3):117-24. PubMed ID: 17886699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection?
    Lobato MN; Jereb JA; Castro KG
    Pediatrics; 2009 Mar; 123(3):902-3. PubMed ID: 19255018
    [No Abstract]   [Full Text] [Related]  

  • 24. Database study of antibiotic resistant tuberculosis in the United Kingdom, 1994-6.
    Irish C; Herbert J; Bennett D; Gilham C; Drobniewski F; Williams R; Smith EG; Magee JG; Watt B; Chadwick M; Watson JM
    BMJ; 1999 Feb; 318(7182):497-8. PubMed ID: 10024255
    [No Abstract]   [Full Text] [Related]  

  • 25. Multiple drug resistant tuberculosis.
    Drobniewski FA; Yates MD
    J Clin Pathol; 1997 Feb; 50(2):89-90. PubMed ID: 9155685
    [No Abstract]   [Full Text] [Related]  

  • 26. Isoniazid resistant TB and non-compliance.
    van Altena R; van Soolingen D; van der Werf TS
    Thorax; 2004 Dec; 59(12):1098; author reply 1098-9. PubMed ID: 15563712
    [No Abstract]   [Full Text] [Related]  

  • 27. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.
    Sungkanuparph S; Eampokalap B; Chottanapund S; Bed ST; Manosuthi W
    J Med Assoc Thai; 2007 May; 90(5):884-8. PubMed ID: 17596041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. XDR-TB: Indian perspective.
    Singh A
    Eur Respir J; 2007 Jul; 30(1):178-9. PubMed ID: 17601976
    [No Abstract]   [Full Text] [Related]  

  • 30. The impact of drug resistance on the global tuberculosis epidemic.
    Schluger NW
    Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S71-5. PubMed ID: 10688153
    [No Abstract]   [Full Text] [Related]  

  • 31. Nationwide survey on the prevalence of anti-tuberculosis drug resistance in the Republic of Yemen, 2004.
    Al-Akhali A; Ohkado A; Fujiki A; Mitarai S; Yamada N; Masui T; Otomo K; Yamada H; Seita A; Mori T; Al-Absi AN
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1328-33. PubMed ID: 18034954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
    Hoopes AJ; Kammerer JS; Harrington TA; Ijaz K; Armstrong LR
    Arch Intern Med; 2008 Oct; 168(18):1984-92. PubMed ID: 18852399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Primary resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Kinshasa, (DRC)].
    Kabedi MJ; Kashongwe M; Kayembe JM; Mumba Ngoyi D; Mampasi P; Mbaya P; Fissette K; Verhaegen J; Portaels F; Muyembe-Tamfum JJ
    Bull Soc Pathol Exot; 2007 Oct; 100(4):275-6. PubMed ID: 17982858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TB surveillance in correctional institutions in Hong Kong, 1999-2005.
    Wong MY; Leung CC; Tam CM; Kam KM; Ma CH; Au KF
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):93-8. PubMed ID: 18173884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiometric vs. agar proportion methods for assessing ethionamide resistance and its clinical effects in multidrug-resistant tuberculosis.
    Cimen NO; Arslan Z; Saygi A; Ocak K; Babacan F; Kurutepe M
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):907-13. PubMed ID: 19555543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidrug resistant tuberculosis.
    Millard J; Ugarte-Gil C; Moore DA
    BMJ; 2015 Feb; 350():h882. PubMed ID: 25721508
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis recommendations.
    Coker RJ
    Sex Transm Infect; 1998 Aug; 74(4):240-2. PubMed ID: 9924460
    [No Abstract]   [Full Text] [Related]  

  • 39. XDR-TB: entering the post-antibiotic era?
    Raviglione M
    Int J Tuberc Lung Dis; 2006 Nov; 10(11):1185-7. PubMed ID: 17131774
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of multidrug-resistant tuberculosis: Update 2007.
    Yew WW; Leung CC
    Respirology; 2008 Jan; 13(1):21-46. PubMed ID: 18197909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.